DoseLab version 6.60 released

Mobius Medical Systems is pleased to announce the official release of DoseLab version 6.60. All DoseLab and FractionLab (formerly FractionCheck) users with active maintenance agreements may now upgrade their software; available after logging in at www.mobiusmed.com/support. Version 6.60 includes many new features and improvements which are listed in detail at the version history page. A few of the new features …

DoseLab TG-142 available for sale in the US

On February 10th, 2014, the United States FDA clarified their position in regards to Mobius’ DoseLab TG-142 and FractionLab software products. Both DoseLab TG-142 and FractionLab are properly classified as machine QA devices as §892.1940 (LHO). The use of treatment log files to perform patient-specific QA is a MobiusFX exclusive feature.

United States Device Reclassifications

On January 6, 2014, the US FDA informed Mobius Medical Systems of a need to reclassify our Mobius3D and MobiusFX software under different product codes. They also requested further information about the classification of DoseLab Pro. DoseLab TG-142 and FractionLab are not affected by this action. As a result, the affected products will only be available for sale outside of …

Mobius Medical Wins Preliminary Injunction Against Sun Nuclear

On December 10, 2013, the Honorable Melinda Harmon, United States District Judge for the Southern District of Texas, Houston Division, granted Mobius’s request for a preliminary injunction enjoining Sun Nuclear Corporation’s continued misappropriation of Mobius’s trade secrets. Judge Harmon enjoined Sun Nuclear from “promoting, marketing, advertising, selling, and offering for sale” Sun’s ImagePro product, and any other products derived through …

DoseLab 6.60 Beta Released

All users with active maintenance agreements may now upgrade their software to version 6.60 Beta; available after logging in at the Mobius Medical website. Version 6.60 Beta includes many new features and improvements such as: The ability to create custom tests and track any type of QA results in the database View database results for more than one machine at …

Mobius3D Version 1.3 Introduces A Paradigm Shift In Patient Specific QA

Mobius Medical Systems’ Mobius3D version 1.3 formally introduces the MobiusFX add-on allowing users to complete their IMRT/VMAT QA in as little as one minute! Mobius Medical Systems, LP announces the release of the latest version of their flagship software product Mobius3D. Version 1.3 introduces a host of new features, including the official release of the MobiusFX add-on. MobiusFX provides clinicians …

Mobius3D version 1.3 with MobiusFX released

We’re happy to announce that Mobius3D v 1.3 is now available for download. Mobius3D v1.3 includes the clinical release of the MobiusFX add-on. MobiusFX currently supports single-fraction QA checks using Varian DynaLog and Varian Trajectory Log files. Trial access to MobiusFX is enabled for all Mobius3D users while we continue development of more planned MobiusFX features including Elekta support and …

Mobius Clarifies DoseLab Software Distribution

Mobius released DoseLab in April, 2010. Since then, DoseLab has become the gold standard in TG-142 QA, providing today’s medical physicists with a powerful, efficient, and vendor-neutral approach to machine QA.

Sun Nuclear / Mobius Joint Statement

Sun Nuclear / Mobius Joint Statement: Effective September 8, 2013 for the US market, and January 1, 2014, for non-US markets, Sun Nuclear Corporation will transition from an exclusive to non-exclusive distributor of DoseLab and FractionCHECK. Both products will continue to be offered by Sun Nuclear as well as the manufacturer, Mobius Medical Systems, LP.

AAPM iPad Mini Winner

August 7, 2013 – Indianapolis, IN Mobius Medical Systems would like to congratulate Patrick Silgen, Medical Physicist at Park Nicollet Methodist Hospital in St. Louis Park, MN for winning the iPad Mini given away at the 55th Annual AAPM Meeting in Indianapolis, IN.  Patrick’s name was drawn from over 400 entry forms by MMS Founder, Dr. Nathan Childress.  We would …